These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37766246)

  • 1. Effect of Different Levels of Maternally Derived Genotype VII Newcastle Disease Virus-Specific Hemagglutination Inhibition Antibodies on Protection against Virulent Challenge in Chicks.
    Liu M; Shen X; Yu Y; Li J; Fan J; Jia X; Dai Y
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX.
    Liu M; Shen X; Li J; Yu Y; Fan J; Jia X; Dai Y
    Vet Immunol Immunopathol; 2023 May; 259():110591. PubMed ID: 37030151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Impact of Different Administration Routes on the Efficacy of a Thermoresistant Newcastle Disease Vaccine in Chickens.
    Hassanzadeh M; Abdoshah M; Yousefi AR; Masoudi S
    Viral Immunol; 2020 Jun; 33(5):361-366. PubMed ID: 31976824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of genotype-matched Newcastle disease virus vaccine formulated in carboxymethyl sago starch acid hydrogel in chickens vaccinated via different routes.
    Mahamud SNA; Bello MB; Ideris A; Omar AR
    J Vet Sci; 2022 Jul; 23(4):e25. PubMed ID: 35920119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
    Wajid A; Basharat A; Bibi T; Rehmani SF
    Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
    Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
    PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Newcastle disease virus genotype VII-mismatched vaccines in SPF chickens: A challenge efficacy study.
    Hassanzadeh M; Abedi M; Bashashati M; Yousefi AR; Abdoshah M; Mirzaie S
    Vet Anim Sci; 2024 Jun; 24():100348. PubMed ID: 38623086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protection conferred against virulent Newcastle disease virus (vNDV) genotype VII by commercial double recombinant HVT vaccines and NDV live-attenuated vaccine as prime/boost vaccination regimens in commercial broiler chickens carrying maternally-derived antibodies (MDAs) against NDV.
    Ghanem IAE; Abdullatif TM; Hassanin O
    Avian Pathol; 2023 Aug; 52(4):251-263. PubMed ID: 37158499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
    Liu H; de Almeida RS; Gil P; Majó N; Nofrarías M; Briand FX; Jestin V; Albina E
    Vaccine; 2018 Jun; 36(27):3917-3925. PubMed ID: 29843999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of inactivated avian influenza virus and Newcastle disease virus bivalent vaccination program against newly circulated H5N8 and NDV strains.
    Azab AA; Yehia N; Makhareta M; Samir M; Shoukry A; Elhalem Mohamed AA; Alhag SK; Alwabli AS; El-Saadony MT; El-Tarabily KA; Soliman MA
    Poult Sci; 2023 Oct; 102(10):102952. PubMed ID: 37634266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
    Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of binary ethylenimine-inactivated vaccines of Gianyar-1/AK/2014 virulent strain in protecting chickens against Tabanan-1/ARP/2017 virulent Newcastle disease virus isolates.
    Adi AAAM; Astawa INM; Putra IGAA
    Vet World; 2019 Jun; 12(6):758-764. PubMed ID: 31439989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.